Check-CapCHEKZ 31 Operating Margin % is 0.00% as of Dec. 2025. GuruFocus rates CHEKZ with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Check-Cap ranks worse than 490195.59% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Check-Cap's Operating Income for the
six
months ended in Dec. 2025 was $-1.04 Mil. Check-Cap's Revenue for the
six
months ended in Dec. 2025 was $0.00 Mil. Therefore, Check-Cap's Operating Margin % for the quarter that ended in Dec. 2025 was 0.00%.
The historical rank and industry rank for Check-Cap's Operating Margin % or its related term are showing as below:
CHEKZ's Operating Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -3.195 * Ranked among companies with meaningful Operating Margin % only.
Check-Cap's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Check-Cap's Operating Income for the
six
months ended in Dec. 2025 was $-1.04 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.37 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Check-Cap Operating Margin % Related Terms
Check-Cap Operating Margin % Historical Data
* Premium members only.
The historical data trend for Check-Cap's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHEKZ vs XWEL, NDRA, NOTV: Operating Margin % Comparison
For the Diagnostics & Research subindustry, Check-Cap's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Check-Cap Operating Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Check-Cap's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Check-Cap's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Check-Cap's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Check-Cap (CHEKZ) has a Operating Margin % of 0.00% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Check-Cap and its competitors. According to the industry distribution chart, Check-Cap ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry.
Is Check-Cap's Operating Margin % too high?
Check-Cap's current Operating Margin % is 0.00%. Based on the distribution chart, Check-Cap ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Check-Cap has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Check-Cap's Operating Margin % compare to XWEL and NDRA?
According to the Medical Diagnostics & Research industry distribution chart, Check-Cap ranks #999999 out of 204 companies for Operating Margin %. This places Check-Cap in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Check-Cap and its competitors. Check-Cap's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Check-Cap stock overvalued right now?
Check-Cap (CHEKZ) has a current Operating Margin % of 0.00%. The current Operating Margin % is 0.00%. Check-Cap's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Check-Cap (CHEKZ), the current Operating Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.
31GF Score
Get the complete analysis for CHEKZ
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHEKZ has been successfully added to your 
